Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guzzo

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Arthritis and Rheumatism|August 1, 2007
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2D van der Heijde, A Kavanaugh, D D Gladman, et al.
Annals of the Rheumatic Diseases|November 23, 2006
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trialA Kavanaugh, G G Krueger, A Beutler, et al.
Journal of the American Academy of Dermatology|March 1, 1997
Cyclosporine as maintenance therapy in patients with severe psoriasisJ Shupack, E Abel, E Bauer, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 19, 2006
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgeryA B Barroso, V Lima, G C Guzzo, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Arthritis and Rheumatism|August 1, 2007
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2D van der Heijde, A Kavanaugh, D D Gladman, et al.
Annals of the Rheumatic Diseases|November 23, 2006
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trialA Kavanaugh, G G Krueger, A Beutler, et al.
Journal of the American Academy of Dermatology|March 1, 1997
Cyclosporine as maintenance therapy in patients with severe psoriasisJ Shupack, E Abel, E Bauer, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 19, 2006
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgeryA B Barroso, V Lima, G C Guzzo, et al.
Pageof 6